Literature DB >> 20151385

Two new sesquiterpene derivatives from the Tunisian endemic Ferula tunetana Pom.

Aymen Jabrane1, Hichem Ben Jannet, Zine Mighri, Jean-François Mirjolet, Olivier Duchamp, Féthia Harzallah-Skhiri, Marie-Aleth Lacaille-Dubois.   

Abstract

A new sesquiterpene ester, tunetanin A (1), a new sesquiterpene coumarin, tunetacoumarin A (2), together with eight known compounds, i.e., coladin (3), coladonin (4), isosmarcandin (5), 13-hydroxyfeselol (6), umbelliprenin (7) propiophenone (8), beta-sitosterol (9), and stigmasterol (10), were isolated from the roots of Ferula tunetana. Their structures were elucidated on the basis of extensive spectroscopic methods, including 1D- and 2D-NMR experiments and MS analysis, as well as by comparison with published data. The cytotoxicity of compounds 1-7 towards two human colon cancer cell lines, HT-29 and HCT 116, was evaluated. Compounds 3, 4, and 6 showed weak cytotoxic activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151385     DOI: 10.1002/cbdv.200900025

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  3 in total

1.  Comparative analysis of the cytotoxic effect of 7-prenyloxycoumarin compounds and herniarin on MCF-7 cell line.

Authors:  Seyed Hadi Mousavi; Atiyeh-Sadat Davari; Mehrdad Iranshahi; Sarvenaz Sabouri-Rad; Zahra Tayarani Najaran
Journal:  Avicenna J Phytomed       Date:  2015 Nov-Dec

2.  Next Chapter in the Legend of Silphion: Preliminary Morphological, Chemical, Biological and Pharmacological Evaluations, Initial Conservation Studies, and Reassessment of the Regional Extinction Event.

Authors:  Mahmut Miski
Journal:  Plants (Basel)       Date:  2021-01-06

3.  Carotane sesquiterpenes from Ferula vesceritensis: in silico analysis as SARS-CoV-2 binding inhibitors.

Authors:  Tarik A Mohamed; Abdelsamed I Elshamy; Mahmoud A A Ibrahim; Ammar Zellagui; Mahmoud F Moustafa; Alaa H M Abdelrahman; Shinji Ohta; Paul W Pare; Mohamed-Elamir F Hegazy
Journal:  RSC Adv       Date:  2020-09-18       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.